Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Profound Medical Announces Initiation of TULSA Clinical Trial for Treatment of Localized Prostate Cancer
Toronto, Canada (April 25, 2013) - Profound Medical Inc. today announced the commencement of its Health Canada approved, multi-center TULSA... Read more
Affinium Pharmaceuticals Announces Positive Efficacy, Safety, and Tolerability Results from Phase 2a Clinical Trial
Austin, Texas and Toronto, Ontario, March 20, 2013 - Affinium Pharmaceuticals annonced today that its Phase 2a clinical trial evaluating... Read more